Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer.

[1]  A. Camins,et al.  Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation , 2022, Pharmaceutics.

[2]  X. Walboomers,et al.  A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide , 2021, RSC advances.

[3]  B. Baradaran,et al.  Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. A. Castro‐Osma,et al.  Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment , 2021, Cancers.

[5]  P. Loyer,et al.  Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma Cells , 2021, Nanomaterials.

[6]  A. Russo,et al.  Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives , 2020, Nucleic acids research.

[7]  P. G. Frank,et al.  EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity , 2020, International journal of molecular sciences.

[8]  Isabel Gessner,et al.  Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy , 2020, International journal of molecular sciences.

[9]  A. Russo,et al.  uL3 Mediated Nucleolar Stress Pathway as a New Mechanism of Action of Antiproliferative G-quadruplex TBA Derivatives in Colon Cancer Cells , 2020, Biomolecules.

[10]  F. Fiorino,et al.  Anticancer activities of fatty acids and their heterocyclic derivatives. , 2020, European journal of pharmacology.

[11]  F. Atyabi,et al.  S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles containing Imatinib for targeting drug delivery to atherosclerotic plaques , 2020, DARU Journal of Pharmaceutical Sciences.

[12]  M. Zoli,et al.  PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study , 2020, Pharmaceutics.

[13]  F. Ungaro,et al.  Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media , 2019, Nanomaterials.

[14]  F. Ungaro,et al.  Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity. , 2019, Materials science & engineering. C, Materials for biological applications.

[15]  Amanda K. Pearce,et al.  Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine. , 2019, Bioconjugate chemistry.

[16]  J. Feijen,et al.  Peptide‐decorated polymeric nanomedicines for precision cancer therapy , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[17]  A. Barbieri,et al.  Biodegradable nanoparticles bearing amine groups as a strategy to alter surface features, biological identity and accumulation in a lung metastasis model. , 2018, Journal of materials chemistry. B.

[18]  X. Jing,et al.  Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease , 2018, Drug delivery.

[19]  Hui Cai,et al.  Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. , 2017, International journal of pharmaceutics.

[20]  E. Ruoslahti.  Tumor penetrating peptides for improved drug delivery , 2017, Advanced drug delivery reviews.

[21]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[22]  Jan Baumann,et al.  Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells , 2016, BMC Cancer.

[23]  N. Samani,et al.  VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish , 2015, Proceedings of the National Academy of Sciences.

[24]  T. Rawling,et al.  Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs. , 2015, Pharmacology & therapeutics.

[25]  F. Ungaro,et al.  Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells , 2015, Journal of Nanobiotechnology.

[26]  S. Kizaka-Kondoh,et al.  Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[27]  R. Gambari,et al.  Antibacterial and anti‐inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis , 2014, Journal of peptide science : an official publication of the European Peptide Society.

[28]  Quanyin Hu,et al.  iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. , 2014, Biomaterials.

[29]  F. Shibasaki,et al.  [Cell-penetrating peptide]. , 2013, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[30]  E. Ruoslahti,et al.  De novo design of a tumor-penetrating peptide. , 2013, Cancer research.

[31]  K. Kaur,et al.  NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences. , 2012, ACS combinatorial science.

[32]  V. Yang,et al.  Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. , 2011, Biomaterials.

[33]  Na Zhang,et al.  Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Igor L. Medintz,et al.  Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. , 2010, Therapeutic delivery.

[35]  E. Ruoslahti,et al.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.

[36]  I. Brown,et al.  Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF‐κB pathway , 2008, The Prostate.

[37]  K. Hamad-Schifferli,et al.  Structure and function of nanoparticle–protein conjugates , 2008, Biomedical materials.

[38]  A. Russo,et al.  Cannabinoids reduce granuloma‐associated angiogenesis in rats by controlling transcription and expression of mast cell protease‐5 , 2008, British journal of pharmacology.

[39]  A. Hutcheon,et al.  Potentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[40]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[41]  T. Hoffmann,et al.  Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.

[42]  R. Shivers,et al.  'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. , 2000, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.